India’s rapid healthcare expansion highlights the urgent need to ensure that growth translates into making healthcare affordable for a larger population
India is strengthening its healthcare ecosystem through new institutional collaborations to accelerate Medical Research in India, with a clear focus on improving patient-centric outcomes through data-backed and evidence-based practices
The latest BRICS Health Ministers’ meeting signals a notable shift in that direction, also mental health is increasingly gaining recognition as a critical component of global healthcare
Cipla has reported its highest-ever quarterly sales record in India, marking a strong start to Q1 FY27. The company's domestic business grew 12 percent year-on-year and became the biggest growth driver. Cipla also delivered steady gains across globa
Roche has reaffirmed its full-year guidance, keeping Roche's Growth Story alive despite Vabysmo slowdown sales and ongoing currency headwinds.
The pharmaceutical and healthcare industry continues to evolve rapidly, driven by policy changes, strategic investments, scientific breakthroughs, and regulatory developments.
Patients using GLP-1 drugs for obesity and type 2 diabetes may have a slightly higher chance of developing hair loss, according to three new studies.
GSK has received Early FDA Approval for its new lung cancer drug, Jideytro. The decision marks a major milestone for the company as it enters the competitive market for targeted lung cancer therapies.
The 6th Edition Drug Safety Symposium 2026 – India Chapter, organized by Eminence Business Media, concluded successfully in Mumbai, reaffirming its position as one of India's leading knowledge
The Congo Ebola Crisis has entered another critical phase. The outbreak has now recorded 2,473 confirmed cases and 999 deaths. The latest figures mark a sharp rise from previous updates.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")